Statements Author contributions XC: writing original draft preparation and software
Review your plan's formulary to see whether it covers other weight loss GLP-1s, such as Wegovy or Foundayo ( orforglipron )
Slow breathing, walking, and time outdoors help regulate the system that raises cortisol in the first place
The shift towards personalized medicine is expected to increase the use of pharmacogenetics in the clinical trial phase thereby increasing the pipeline of drugs
Each of those programmes requires robust supply chains, validated cleanroom manufacturing, precision moulding, automated assembly and long-term capacity commitments
Key Uses: Type 2 Diabetes Mellitus Chronic weight management (in adults with obesity or overweight with comorbidities) Side Effects: Nausea, vomiting, diarrhea Decreased appetite Injection site reactions Rare: Pancreatitis, gallbladder disease Important Note: Not for Type 1 Diabetes or diabetic ketoacidosis Gradually increase dose to minimize GI side effects Monitor for signs of pancreatitis and gallbladder issues Fun Fact: Tirzepatide mimics two natural gut hormones (GIP & GLP-1) making it the first dual-action drug of its kind
